Skip to main content
. 2014 Dec 4;308(3):F252–F260. doi: 10.1152/ajprenal.00596.2014

Fig. 1.

Fig. 1.

Blood pressure (BP) and proteinuria at baseline and during chronic administration of Nω-nitro-l-arginine methyl ester (l-NAME) or ANG II. A: radiotelemetrically measured systolic BP at baseline and averaged over 48-h intervals during the 4-wk administration of l-NAME or ANG II. *P < 0.05 vs. l-NAME at the respective time point. B: 24-h proteinuria at baseline and at the second and fourth wk of l-NAME or ANG II. Values are expressed as means ± SE. *P < 0.05 vs. ANG II at 4 wk.